Inhibition of murine erythroid colony formation in vitro by interferon gamma and correction by interferon receptor immunoadhesin.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Blood

• Publication date

  1994-02-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V83.4.911.BLOODJOURNAL834911PMID 8111063
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of interferon-gamma by an interferon-gamma receptor immunoadhesin.

  1993cited by this paper
• Inhibition of human erythroid colony‐forming units by interleukin‐1 is mediated by gamma interferon

  1992cited by this paper
• Progress in understanding the pathogenesis of the anemia of chronic disease.

  1992cited by this paper
• Interleukin 1 receptor antagonist. A new member of the interleukin 1 family.

  1991cited by this paper
• Inhibition of human erythroid colony-forming units by gamma interferon can be corrected by recombinant human erythropoietin.

  1991cited by this paper
• Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin.

  1991cited by this paper
• Biological properties of a CD4 immunoadhesin

  1990cited by this paper
• Correlation between neopterin, interferon‐gamma and haemoglobin in patients with haematological disorders

  1990cited by this paper
• Regulation of alloreactivity in vivo by a soluble form of the interleukin-1 receptor.

  1990cited by this paper
• Macrophage control of normal and leukemic erythropoiesis: identification of the macrophage-derived erythroid suppressing activity as interleukin-1 and the mediator of its in vivo action as tumor necrosis factor.

  1990cited by this paper
• Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis.

  1990cited by this paper
• Designing CD4 immunoadhesins for AIDS therapy.

  1990cited by this paper
• The Interferon-γ Receptor: A Comparison with Other Cytokine Receptors

  1990cited by this paper
• Interferon-gamma concentrations are increased in sera from individuals infected with human immunodeficiency virus type 1.

  1989cited by this paper
• Designing CD4 immunoadhesins for AIDS therapy

  1989cited by this paper
• Treatment of the anemia of rheumatoid arthritis with recombinant human erythropoietin: clinical and in vitro studies.

  1989cited by this paper
• Mechanism of anaemia in rheumatoid arthritis: demonstration of raised interleukin 1 beta concentrations in anaemic patients and of interleukin 1 mediated suppression of normal erythropoiesis and proliferation of human erythroleukaemia (HEL) cells in vitro.

  1988cited by this paper
• Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis.

  1988cited by this paper
• Purification of human erythroid colony-forming units and demonstration of specific binding of erythropoietin.

  1987cited by this paper
• Lymphocytes and lymphokines in aplastic anemia: pathogenic role and implications for pathogenesis.

  1987cited by this paper
• Large-scale procurement of erythropoietin-responsive erythroid cells: assay for biological activity of erythropoietin.

  1987cited by this paper
• Studies of interferon as a regulator of hematopoietic cell proliferation.

  1985cited by this paper
• Suppression of normal human erythropoiesis by gamma interferon in vitro. Role of monocytes and T lymphocytes.

  1985cited by this paper
• Erythropoiesis in culture.

  1984cited by this paper
• Receptors for human gamma interferon: binding and crosslinking of 125I-labeled recombinant human gamma interferon to receptors on WISH cells.

  1984cited by this paper
• Erythropoiesis in culture.

  1984cited by this paper
• The anemia of chronic disease.

  1983cited by this paper
• Induction of colonies of hemoglobin-synthesizing cells by erythropoietin in vitro.

  1971cited by this paper

• Dynamics in Anemia Development and Dysregulation of Iron Homeostasis in Hospitalized Patients with COVID-19

  2021cites this paper
• Recent Advances of Sarcopenia and Frailty in CKD

  2020cites this paper
• Anemia Management and QOL and Frailty in CKD

  2020cites this paper
• Acquired Aplastic Anemia as a Clonal Disorder of Hematopoietic Stem Cells

  2020cites this paper
• Chrysin protects mice liver and kidney from methandienone-induced oxi-dative ‎stress, inflammation a multi-biomarker approach

  2019cites this paper
• The Anemia of Inflammation/Chronic Disease and the Unexplained Anemia of the Elderly

  2019cites this paper
• Reduced Parasite Burden in Children with Falciparum Malaria and Bacteremia Coinfections: Role of Mediators of Inflammation

  2016cites this paper
• Interferon-γ suppresses activin A/NF-E2 induction of erythroid gene expression through the NF-κB/c-Jun pathway.

  2014cites this paper
• Interferon-γ mediates anemia but is dispensable for Fulminant Toll-Like Receptor 9-induced Macrophage Activation Syndrome and Hemophagocytosis

  2013cites this paper
• Interferon-γ mediates anemia but is dispensable for fulminant toll-like receptor 9-induced macrophage activation syndrome and hemophagocytosis in mice.

  2013cites this paper
• Differential effects of IFN-γ on erythropoiesis in bone marrow versus spleen

  2013cites this paper
• Stat and interferon genes identified by network analysis differentially regulate primitive and definitive erythropoiesis

  2013cites this paper
• The role of CD4+ T cells in Friend virus infection

  2011cites this paper
• Hsp70 est un nouveau régulateur majeur de l'érythropoïèse empêchant le clivage du facteur de transcription GATA-1 par la caspase-3 au cours de la différenciation.

  2010cites this paper
• High serum levels of TNF-α and IL-6 predict the clinical outcome of treatment with human recombinant erythropoietin in anaemic cancer patients.

  2010cites this paper
• Hyporesponsiveness to erythropoiesis stimulating agents in chronic kidney disease: the many faces of inflammation.

  2009cites this paper
• STAT6-mediated suppression of erythropoiesis in an experimental model of malarial anemia

  2009cites this paper
• Fluorine-18 Fluorodeoxyglucose with Positron Emission Tomography Revealed Bone Marrow Involvement in Sarcoidosis Patients with Anaemia

  2009cites this paper
• The Anemia of Chronic Inflammation

  2008cites this paper
• Association of Insulin Resistance with de novo Coronary Stenosis after Percutaneous Coronary Artery Intervention in Hemodialysis Patients

  2008cites this paper
• Is C-Reactive Protein a Reliable Risk Factor of Cardiovascular Morbidity and Mortality in Clinical Practice?

  2008cites this paper
• The anemia of inflammation/malignancy: mechanisms and management.

  2008cites this paper
• Gamma Interferon Suppresses Erythropoiesis via Interleukin-15

  2007cites this paper
• Toxicity as a result of immunostimulation by biologics

  2007cites this paper
• Gamma Interferon Suppresses Erythropoiesis via Interleukin-15

  2007cites this paper
• Interferon-gamma mediates suppression of erythropoiesis but not reduced red cell survival following CpG-ODN administration in vivo.

  2006cites this paper
• A novel role for STAT1 in regulating murine erythropoiesis: deletion of STAT1 results in overall reduction of erythroid progenitors and alters their distribution.

  2005cites this paper
• CME: CLINICAL PRACTICE AND ITS BASIS

  2005cites this paper
• A Common Cause of Anemia in Inflammatory Disorders: Anemia of Chronic Disease

  2005cites this paper
• Haematological manifestations of systemic disease.

  2005cites this paper
• Failure of interferon-gamma and tumor necrosis factor in mediating anemia of chronic disease in a mouse model of protracted septic peritonitis.

  2005cites this paper
• Malarial anaemia: mechanisms and implications of insufficient erythropoiesis during blood-stage malaria.

  2004cites this paper
• Stem cell factor increases the expression of FLIP that inhibits IFNgamma -induced apoptosis in human erythroid progenitor cells.

  2003cites this paper
• TNF-Independent Development of Transient Anemia of Chronic Disease in a Mouse Model of Protracted Septic Peritonitis

  2003cites this paper
• Temporal Effects of Gamma Interferon Deficiency on the Course of Friend Retrovirus Infection in Mice

  2002cites this paper
• Anemia de Doença Crônica

  2002cites this paper
• Role of Interleukin-4 (IL-4), IL-12, and Gamma Interferon in Primary and Vaccine-Primed Immune Responses to Friend Retrovirus Infection

  2001cites this paper
• 67 – Cytokine Biology

  2001cites this paper
• The anaemia of infection.

  2000cites this paper
• Advances in the anemia of chronic disease.

  1999cites this paper
• Interferon γ Induces Upregulation and Activation of Caspases 1, 3, and 8 to Produce Apoptosis in Human Erythroid Progenitor Cells

  1999cites this paper
• Analysis of erythropoietin and erythropoietin receptor genes expression in cattle during acute infection with Trypanosoma congolense.

  1999cites this paper
• Pathophysiology of the Anemia of Malignancy

  1999cites this paper
• Interferon gamma induces upregulation and activation of caspases 1, 3, and 8 to produce apoptosis in human erythroid progenitor cells.

  1999cites this paper
• HEMATOPOIESIS Interferon g Induces Upregulation and Activation of Caspases 1, 3, and 8 to Produce Apoptosis in Human Erythroid Progenitor Cells

  1999cites this paper
• Fas ligand is present in human erythroid colony-forming cells and interacts with Fas induced by interferon gamma to produce erythroid cell apoptosis.

  1998cites this paper
• Cloning, expression, and characterization of a novel guanylate-binding protein, GBP3 in murine erythroid progenitor cells.

  1998cites this paper
• Interferons in dermatology. Present-day standard.

  1998cites this paper
• Use of the medical differential diagnosis to achieve optimal end-stage renal disease outcomes.

  1997cites this paper
• Cytokines and anaemia in human immunodeficiency virus infection.

  1997cites this paper
• Inducible nitric oxide synthase expression and erythropoietin production in human hepatocellular carcinoma cells.

  1997cites this paper
• A potential role for nitric oxide in dyserythropoiesis

  1996cites this paper
• The immune response to murine retroviral infection

  1996cites this paper
• Erythropoietin and the anemia of cancer.

  1996cites this paper
• Pathogenesis of the anemia of chronic disease: A cytokine‐mediated anemia

  1995cites this paper
• Stem cell factor can overcome inhibition of highly purified human burst‐forming units‐erythroid by interferon γ

  1995cites this paper
• Role of interferon-gamma in immune cell regulation.

  1995cites this paper
• Role of interferon‐γ in immune cell regulation

  1995cites this paper
• Clinical application of recombinant erythropoietin in the anemia of chronic disease.

  1994cites this paper